Latest Royalties News

Pilbara Minerals reported a 14% drop in spodumene concentrate production for December Quarter FY25 amid operational shifts, yet revenue rose 3% driven by higher prices. The company advances its P1000 Project and secures approval to acquire Latin Resources, signaling growth ambitions.

Lindian Resources has secured a US$50 million non-binding funding term sheet with Gerald Group, progressing its Kangankunde Rare Earths Project, while also signing a 10-year lease for its Woula bauxite project in Guinea and navigating significant board changes.

Empire Resources reports encouraging aircore drilling results at its Yuinmery Project, revealing significant copper and gold mineralisation that extends over substantial strike lengths. Follow-up drilling is set to deepen exploration in early 2025.

Burgundy Diamond Mines reported a dip in Q4-2024 production and revenue amid operational transitions but maintains a bullish outlook for 2025 driven by strategic mine development and market recovery.

Red Hawk Mining Limited has issued a Target’s Statement recommending shareholders accept Fortescue’s off-market takeover offer at $1.05 per share, rising to $1.20 if Fortescue secures 75% ownership. An independent expert confirms the offer is fair and reasonable, providing a significant premium and resolving funding uncertainties for Red Hawk’s Blacksmith Project.

Fitzroy River Corporation's latest quarterly report reveals a dip in royalty income but highlights progress on major silver and gold projects, alongside strategic moves in energy royalties.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.

Metro Mining Limited delivered record bauxite shipments in Q4 2024, alongside a successful debt restructure and strong EBITDA margins, positioning the company for growth amid rising market prices.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Gold Road Resources projects a significant production increase at Gruyere in 2025 and has initiated underground drilling to potentially extend mine life beyond 2032.

Astral Resources has reported its most significant diamond drilling results to date at the Theia Deposit within the Mandilla Gold Project, with drill-hole MDRCD918 delivering an exceptional 1,079 gram-metres of gold mineralisation. This breakthrough is expected to underpin an upgrade of the resource classification ahead of a Mineral Resource Estimate update scheduled for March 2025.